Clinical Study

Survival Advantage Associated with Decrease in Stage at Detection from Stage IIIC to Stage IIIA Epithelial Ovarian Cancer

Figure 1

(a) Overall survival of Stage IIIA versus Stage IIIC epithelial ovarian cancer patients at the University of Kentucky Markey Cancer Center (2000–2009). (b) Overall survival of Stage IIIA versus Stage IIIC epithelial ovarian cancer patients in SEER*18 Registries (2000–2009).
312193.fig.001a
(a)
312193.fig.001b
(b)